1. Academic Validation
  2. Pachymic acid (PA) inhibits ferroptosis of cardiomyocytes via activation of the AMPK in mice with ischemia/reperfusion-induced myocardial injury

Pachymic acid (PA) inhibits ferroptosis of cardiomyocytes via activation of the AMPK in mice with ischemia/reperfusion-induced myocardial injury

  • Cell Biol Int. 2023 Sep 26. doi: 10.1002/cbin.12090.
Dongmin Liu 1 Jiru Ding 2 Zhenzhen Li 3 Youquan Lu 3
Affiliations

Affiliations

  • 1 Cardiovascular Department I, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, China.
  • 2 Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • 3 Shaanxi University of Chinese Medicine, Xianyang, China.
Abstract

Pachymic acid (PA) is a lanostane-type triterpenoid with various pharmacological effects. However, little is known about the effect of PA on myocardial infarction (MI) induced by ischemia/reperfusion (I/R). In this study, we aimed to investigate the protective effect of PA and its underlying mechanism. A cellular MI model was established by oxygen-glucose deprivation and reperfusion (OGD/R) treatment in HL-1 cardiomyocytes, and we found that OGD/R treatment decreased cell viability and glutathione peroxide (GSH-Px) activity, increased Fe2+ concentration and Lactate Dehydrogenase (LDH) activity, promoted malondialdehyde (MDA) and Reactive Oxygen Species (ROS) production, and inhibited the expression of Ferroptosis marker proteins SLC7A11 and GPX4 in a time-dependent manner. OGD/R-induced HL-1 cells were pretreated with different concentrations of PA (0, 20, 40, 60 μg/mL) for 24 h, and toxicological experiments showed that 150 μg/mL PA decreased cell viability, while low concentrations of PA had no toxic effect on cells. 20 μg/mL PA reversed the inhibitory effect of OGD/R on cell viability, reduced MDA and ROS production, and Fe2+ accumulation, increased GSH-Px activity and the expression of SLC7A11 and GPX4, and decreased LDH activity, especially at 60 μg/mL PA. Meanwhile, PA promoted the phosphorylation of IRS-1, Akt, and AMPK proteins in a dose-dependent manner. AICAR, an AMPK Activator, inhibited Ferroptosis, while STO-609, an AMPK Inhibitor, largely abolished the effect of PA on OGD/R-induced Ferroptosis of HL-1 cells. In addition, PA inhibited Ferroptosis and myocardial I/R injury in wild-type mice and AMPK knockout (AMPK-/- ) mice. Collectively, PA inhibited Ferroptosis of cardiomyocytes through activating of the AMPK pathway, thereby alleviating myocardial I/R injury in mice.

Keywords

IRS-1/AKT/AMPK; ferroptosis; myocardial ischemia/reperfusion; pachymic acid; pathway AMPK−/− mice.

Figures
Products
Inhibitors & Agonists
Other Products